Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis

Journal of Rheumatology

Volumn 36, Issue 11, 2009, Pages 2403-2408

  Stamp, Lisa K ^a   Easson, Andrea ^b   Pettersson, Linda ^b   Highton, John ^b   Hessian, Paul A ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Interleukin 12; Interleukin 17A; Interleukin 23; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 23P19; METHOTREXATE; PREDNISONE; PROTEIN P40; RNA;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; MALE; MIDDLE AGED; MONOCYTES; SYNOVIAL MEMBRANE;

EID: 70450189514     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081304     Document Type: Article

References (20)

1. Kirkham BW, Lassere M, Edmonds J, Juhasz K, Bird P, Lee C, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. Arthritis Rheum 2006;54:1122-1131
2. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-970 (Pubitemid 29215007)
3. Bettelli E, Carrier Y, Gao W, Korn T, Storm T, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238
4. Harrington L, Hatton R, Mangan P, Turner H, Murphy T, Murphy K, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol 2005;6:1123-1132 (Pubitemid 41541790)
5. Chen Z, Tato C, Muul C, Laurence A, O'Shea J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007;56:2936-2946 (Pubitemid 47502740)
6. Hoeve M, Savage N, de Boer T, Langenberg D, Malefyt R, Ottenhoff T, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006;36:661-670
7. Steinman L. The rush to judgement on Th17. J Exp Med 2008;205:1517-1522
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
9. Stamp L, Easson A, Lehnigk U, Highton J, Hessian P. Different T cell subsets in the nodule and synovial membrane - absence of IL-17A in rheumatoid nodules. Arthritis Rheum 2008;58:1601-1608 (Pubitemid 351847513)
10. Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiaed spondyloarthropathy. J Rheumatol 2007;34:2285-2290 (Pubitemid 350076892)
11. Kohno M, Tsutsumi A, Matsui H, Sugihara M, Suzuki T, Mamura M, et al. Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 2008;18:15-22.
12. Kim H-R, Cho M-L, Kim K-W, Juhn J-Y, Hwang S-Y, Yoon C-H, et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kB- and p38 MAPK-dependent signalling pathways. Rheumatology 2007;46:57-64.
13. Kim H-R, Kim H-S, Park M-K, Cho M-L, Lee S-H, Kim H-Y. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand J Rheumatol 2007;36:259-264 (Pubitemid 47346915)
14. Kageyama Y, Ichikawa T, Nagafusa T, Torikai E, Shimazu M, Nagano A. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis. Rheumatol Int 2007;28:137-143 (Pubitemid 350105857)
15. Oppman B, Lesley R, Blom B, Timans Y, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-725
16. Brentano F, Ospelt C, Stanczyk J, Gay R, Gay S, Kyburz D. Abundant expression of the IL-23 subunit p19, but low levels of bioactive IL-23 in the rheumatoid synovium [abstract]. Ann Rheum Dis 2009;68:143-150
17. Deng J, Younge B, Goronzy J, Weyand C. Th17 cells as mediators of vessel wall damage in giant cell arteritis. Arthritis Rheum 2008; Suppl 58:S392.
18. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukuchi J-I, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:1299-1304 Epub 2007 Dec 6.
19. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, et al. Two-sided roles of IL-27: Induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 2006;177:5377-5385 (Pubitemid 44527610)
20. Raza K, Falciani F, Curnow S, Ross E, Lee C-Y, Akbar A, et al. Early rheumatoid arthritis is characterised by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-95.